Browse > Article
http://dx.doi.org/10.5012/bkcs.2010.31.01.069

Syntheses of Idarubicin Analogues Containing a Glucose or Galactose Moiety as a Glycone  

Rho, Young-S. (Department of Chemistry, Chonbuk National University)
Park, Ran (Department of Chemistry, Chonbuk National University)
Kim, Seon-Young (Biochemistry of Medical School, Chonbuk National University)
Yoo, Dong-Jin (Department of Chemistry, Seonam University)
Publication Information
Abstract
The new idarubicin analogues (12 and 13) with a glucose or galactoseas as a glycone were synthesized from daunomycin (2). (+)-4-Demethoxydaunomycinone (6) obtained from reaction of 2 with $AlCl_3$ was converted to 4-trifluoromethanesulfonyl daunomycinone (7) through reaction with trifluoromethanesulfonic anhydride. The treatment of 7 with 1,1-bis-(diphenylphospino)ferrocene/$Pd(OAc)_2$ in triethylamine/formic acid/dioxane provided the idarubicinone (5b). Glycosylation of 7-hydroxy group of 5b with two kinds of tetraacetyl pyranosyl halide (8 and 9) by a modified Koenigs-Knorr procedure and then deacetylation using aqueous 0.1 N LiOH solution and amberlite cationic resin gave the objective materials. The in vitro MTT assay of the analogues (12b and 13a) in comparison with idarubicin (5a) on peripheral blood human promyelocytic-leukemia cell line and human breast cancer cell line were also described.
Keywords
Anthracycline; Idarubicin; Idarubicinone; Glucose; Galactose;
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Lown, J. W. Anthracycline and Anthracenedione-based Anticancer Agents; Elsevier: Amsterdam, 1988.
2 Naff, M. B.; Plownan, J.; Narayanan, V. L. Anthracycline Antibiotics El Khadem, H. S., Ed.; Academic Press: New York, 1982; pp 1-57.
3 Grein, A.; Spalla, C.; Di Marco, A.; Canevazzi, G. Giorn. Microbiol. 1963, 11, 109-118.
4 Du Bost, M.; Ganter, P.; Maral, R.; Niner, L.; Pinnert, S.; Preudhomme, J.; Werner, G. H. C. R. Acad. Sci. 1963, 257, 1813-1815
5 Arcamone, F.; Cassinelli, G.; Franceschi, P.; Mondelli, R.; Orezzi, P.; Penco, S. Gazz. Chim. Ital. 1970, 100, 949-989.
6 Arcamone, F.; Cassinelli, G.; Fantini, G.; Grein, A.; Orezzi, P.; Pol, C.; Spalla, C. Biotechnol. Bioeng. 1969, 11, 1101-1110.   DOI   ScienceOn
7 Keredesky, F. A. J.; Cava, M. P. J. Am. Chem. Soc. 1978, 100, 3635-3636.   DOI
8 Badalassi, F.; Crotti, P.; Di Bubno, C.; D'Arata, F.; Favero, L.; Ramacciotti, A. Tetrahedron: Asymmetry 2001, 12, 3155-3161.   DOI   ScienceOn
9 Sekine, A.; Ohshima, T.; Shibasaki, M. Tetrahedron 2002, 58, 75-82.   DOI   ScienceOn
10 Krohn, K. Tetrahedron 1990, 46, 291-318.
11 Rho, Y. S.; Park, S. H.; Kim, W. J.; Kim, G. I.; Yoo, D. J.; Kang, H. S.;S. R. Synthetic Comm. 2002, 32, 1961-1975.   DOI   ScienceOn
12 Rho, Y. S.; Kim, W. J.; Yoo, D. J.; Kang, H. S.; Chung, S. R. Bull. Kor. Chem. Soc. 2001, 22, 963-968.
13 Priebe, W. Anthracycline Antibiotics, New analogues, Methods of Delivery, and Mechanisms of Actions; ACS Symposium Series 574; American Chemical Society: Washington, DC, 1995; pp 100-114.
14 Arcamone, F. Doxorubicin. Anticancer Antibiotics; Medicinal Chemistry, A Series of Monographs volume 17; Academic Press: London, 1981; Vol. 17, pp 1-369.
15 Mettler, F. P.; Young, D. M.; Ward, J. M. Cancer Res. 1977, 37, 2705-2713.
16 Rho, Y. S.; Kim, S. Y.; Kim, W. J.; Yun, Y. K.; Sin, H. S.; Yoo, D. J. Synthetic Comm. 2004, 34, 3497-3511.   DOI   ScienceOn
17 Rho, Y. S.; Ko, H. K.; Sin, H.; Yoo, D. J. Bull. Korean Chem. Soc. 1999, 20, 1517-1520.
18 Valentina Pizzamiglio, S Fiorano(IT); Walter Cabri, Rozzano(IT); Elio Mapelli, Melzo(IT); US patent 2004/0044189 A1, 2004.
19 Aligiannis, N.; Pouli, N.; Marakos, P.; Skaltsounis, A.-L.; Pratsinis, H. Bioorg. Med. Chem. Lett. 2002, 12, 3505-3507.   DOI   ScienceOn
20 Mortensen, R. W.; Corcoran, O.; Cornett, C.; Sidelmann, U. G.; Troke, J.; Lindon, J. C.; Nicholson, J. K.; Hansen, S. H. J. Pharm. Biomed. Anal. 2001, 24, 477-485   DOI   ScienceOn
21 Arcamone, F.; Bernardi, L.; Giardino, P.; Patelli, B.; Di Marco, A.; Casazza, A. M.; Pratesi, G.; Reggiani, P. Cancer Treat. Rep. 1976, 60, 829-836.
22 Arcamone, F.; Bernald, L.; Patelli, B.; Giardino, P.; Di Marco, A.; Cassaza, A. M.; Soranzo, C.; Pratesi, G. Experientia 1978, 34, 1255-1257.   DOI
23 Hollingshead, L. M.; Faulds, D. Drugs 1991, 42, 690-719.   DOI
24 Neidle, S. Nature 1977, 268, 195-196.   DOI
25 Hauser, F. M.; Hewawasam, P.; Rho, Y. S. J. Org. Chem. 1989, 54, 5110-5114.   DOI
26 Rho, Y. S.; Ko, H. K.; Sin, H. S.; Yoo, D. J. Bull. Kor. Chem. Soc. 1999, 20, 1517-1520.
27 Parker, K. A.; Kallmerten, J. L. Tetrahedron Lett. 1979, 1197-1200.
28 Rho, Y. S.; Ko, H. K.; Kim, W. J.; Yoo, D. J.; Kang, H. S. Bull. Kor. Chem. Soc. 2000, 21, 774-778.
29 Rho, Y. S.; Choi, Y. H.; Kim, G. I.; Sin, H. S.; Yoo, D. J.; Kim, S. H.; Cheong, C. J. Bull. Kor. Chem. Soc. 1999, 20, 551-555.
30 Rukhman, I.; Gutman, A. L. Tetrahedron Lett. 2000, 41, 6889-6892   DOI   ScienceOn
31 Mitchell, M. B.; Whitcombe, I. W. A. Tetrahedron Lett. 2000, 41, 8829-8834.   DOI   ScienceOn
32 Leenders, R. G .G.; Damen, E. W. P.; Bijisterveld, E. J. A.; Scheeren, H. W.; Houba, P. H. J.; Meulen-Muileman, I. H.; Boven, E.; Haisma, H. Bioorg. Med. Chem. 1999, 7, 1597-1610.   DOI   ScienceOn
33 Rho, Y. S.; Park, J. H.; Kim, G. I.; Kim, H. S.; Sin, H. S.; Suh, P. W.; Yoo, D. J. Synthetic Comm. 2004, 34, 1703-1722.   DOI   ScienceOn
34 Sidelmann, U. G.; Gavaghan, C.; Carless, H. A. J.; Farrant, R. D.; Lindon, J. C.; Wilson, I. D.; Nicholson, J. K. Anal. Chem. 1995, 67, 3401-3404.   DOI   ScienceOn
35 Armerigo, W. L. F.; Perrin, D. D. Purification of Laboratory Chemicals, 4th Ed.; Oxford: Butterworth-Heinemann, 1996.
36 Wani, M. C.; Taylor, H. L.; Wall, M. E.; Mcphail, A. T.; Onan, K. D. J. Am. Chem. Soc. 1975, 97, 5955-5956   DOI
37 Hassall, C. H.; Broadhurst, M. J.; Thomas, G. J. J. Chem. Soc. Perkin Trans. 1 1982, 2239-2248.   DOI
38 Fan, S.; Gao, M.; Meng, Q.; Laterra, J. J.; Symons, M. H. Coniglio, S. Oncogene 2005, 24, 1749-1766.   DOI   ScienceOn